This medication benefits T2DM patients through different mechanisms, such as increasing insulin excretion, delaying gastric emptying, inhibiting glucagon production, and decreasing pancreatic beta cell apoptosis [37]. The gene discussed is INS; the disease is type 2 diabetes mellitus.